Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tvardi Therapeutics (TVRD) Return on Capital Employed: 2014-2017

Historic Return on Capital Employed for Tvardi Therapeutics (TVRD) over the last 4 years, with Sep 2017 value amounting to -0.64%.

  • Tvardi Therapeutics' Return on Capital Employed fell 6.00% to -0.64% in Q3 2017 from the same period last year, while for Sep 2017 it was -0.64%, marking a year-over-year decrease of 6.00%. This contributed to the annual value of -0.77% for FY2016, which is 45.00% down from last year.
  • Latest data reveals that Tvardi Therapeutics reported Return on Capital Employed of -0.64% as of Q3 2017, which was up 29.30% from -0.90% recorded in Q2 2017.
  • Over the past 5 years, Tvardi Therapeutics' Return on Capital Employed peaked at -0.05% during Q1 2014, and registered a low of -1.70% during Q1 2017.
  • Its 3-year average for Return on Capital Employed is -0.62%, with a median of -0.47% in 2015.
  • Per our database at Business Quant, Tvardi Therapeutics' Return on Capital Employed increased by 9bps in 2015 and then crashed by 139bps in 2017.
  • Quarterly analysis of 4 years shows Tvardi Therapeutics' Return on Capital Employed stood at -0.32% in 2014, then increased by 9bps to -0.23% in 2015, then tumbled by 74bps to -0.97% in 2016, then fell by 6bps to -0.64% in 2017.
  • Its last three reported values are -0.64% in Q3 2017, -0.90% for Q2 2017, and -1.70% during Q1 2017.